Myriad Genetics reported $166M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Accelerate Diagnostics AXDX:US 8.21M 1.27M
Agilent A:US $ 1813M 229M
Becton, Dickinson and BDX:US $ 6657M 78M
Bio Rad Laboratories BIO:US $ 648.33M 32.61M
Biocept BIOC:US $ 14.1M 2.32M
Bruker BRKR:US $ 880.5M 58M
Danaher DHR:US $ 7547M 593M
Exact Sciences EXAS:US $ 480.95M 36.12M
Fluidigm FLDM:US $ 47.17M 2.4M
Hologic HOLX:US $ 1305.1M 26.4M
Illumina ILMN:US $ 1490M 397M
Johnson & Johnson JNJ:US $ 43390M 1836M
Mettler Toledo International MTD:US 1.09B 59.12M
Myriad Genetics MYGN:US $ 166M 38.3M
Nanostring Technologies NSTG:US $ 49.59M 2.57M
Orasure Technologies OSUR:US $ 55.59M 12.48M
Pacific Biosciences Of California PACB:US $ 61.01M 10.7M
Perkinelmer PKI:US $ 1263.05M 49.31M
Quest Diagnostics DGX:US $ 1700M 53M
Quidel QDEL:US $ 492.66M 169.14M
Repligen RGEN:US $ 424.33M 49.07M
Thermo Fisher Scientific TMO:US $ 12070M 1366M
Veracyte VCYT:US $ 62.54M 1.61M
Waters WAT:US $ 687.83M 7.32M